湖北试点三甲医院开展职称自主评审

2018-04-18 郭婷婷 人民网

今日,记者从湖北省人力资源和社会保障厅了解到,湖北省职改办将在省妇幼保健院、省中医院、省肿瘤医院、鄂东医疗集团、襄阳市中心医院、宜昌市中心医院、十堰市太和医院、十堰市人民医院等8家医疗单位试点开展职称自主评审工作。这是湖北省首次在三甲医院试点开展职称自主评审。据了解,本次试点工作首次探索分类评价,将卫生系列分为临床型和科研型。自主评审范围为本单位在卫生专业技术岗位上从事医、药、护、技的专业技术人员

今日,记者从湖北省人力资源和社会保障厅了解到,湖北省职改办将在省妇幼保健院、省中医院、省肿瘤医院、鄂东医疗集团、襄阳市中心医院、宜昌市中心医院、十堰市太和医院、十堰市人民医院等8家医疗单位试点开展职称自主评审工作。这是湖北省首次在三甲医院试点开展职称自主评审。

据了解,本次试点工作首次探索分类评价,将卫生系列分为临床型和科研型。自主评审范围为本单位在卫生专业技术岗位上从事医、药、护、技的专业技术人员以及从事医学研究的专业技术人员。对主要从事临床工作的人才,重点考察其临床医疗医技水平、实践操作能力和工作业绩;对主要从事科研工作的人才,重点考察其创新能力业绩,突出创新成果的转化应用能力。

在医疗单位试点开展职称自主评审,用人单位可根据本单位实际,探索临床评价和科研评价的新模式;用人单位可根据本单位实际,制定不低于省级标准的单位评价标准,合理设置量化评价要素及量化评分标准。评价更加注重临床实践、医疗安全以及动手能力,强化临床导向。

与此同时,用人单位可以探索更加灵活多样的评价方式。引入国际上更加先进的评价体系,对临床医师进行更加准确的评价,也可以引入社会评价。且评审不限时间、不限评次,由单位自主掌握,方式更加灵活多样。用人单位的职称政策更加透明,评审程序更加规范,监督体系更加完备,评审结果更加公正。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1641637, encodeId=3895164163eb9, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Sep 11 01:49:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365973, encodeId=76e413659e362, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518317, encodeId=23b8151831e5a, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552455, encodeId=51481552455de, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307462, encodeId=a89b30e46264, content=非常好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Apr 20 06:00:47 CST 2018, time=2018-04-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1641637, encodeId=3895164163eb9, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Sep 11 01:49:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365973, encodeId=76e413659e362, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518317, encodeId=23b8151831e5a, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552455, encodeId=51481552455de, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307462, encodeId=a89b30e46264, content=非常好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Apr 20 06:00:47 CST 2018, time=2018-04-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1641637, encodeId=3895164163eb9, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Sep 11 01:49:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365973, encodeId=76e413659e362, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518317, encodeId=23b8151831e5a, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552455, encodeId=51481552455de, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307462, encodeId=a89b30e46264, content=非常好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Apr 20 06:00:47 CST 2018, time=2018-04-20, status=1, ipAttribution=)]
    2018-04-20 xxxx1053
  4. [GetPortalCommentsPageByObjectIdResponse(id=1641637, encodeId=3895164163eb9, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Sep 11 01:49:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365973, encodeId=76e413659e362, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518317, encodeId=23b8151831e5a, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552455, encodeId=51481552455de, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307462, encodeId=a89b30e46264, content=非常好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Apr 20 06:00:47 CST 2018, time=2018-04-20, status=1, ipAttribution=)]
    2018-04-20 陈吴1239
  5. [GetPortalCommentsPageByObjectIdResponse(id=1641637, encodeId=3895164163eb9, content=<a href='/topic/show?id=c1bf91e4162' target=_blank style='color:#2F92EE;'>#试点#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91741, encryptionId=c1bf91e4162, topicName=试点)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a5522833467, createdName=ms1774076774505970, createdTime=Tue Sep 11 01:49:00 CST 2018, time=2018-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1365973, encodeId=76e413659e362, content=<a href='/topic/show?id=468119e04db' target=_blank style='color:#2F92EE;'>#三甲医院#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19704, encryptionId=468119e04db, topicName=三甲医院)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5662228, createdName=mjldent, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1518317, encodeId=23b8151831e5a, content=<a href='/topic/show?id=74f180652b9' target=_blank style='color:#2F92EE;'>#职称#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80652, encryptionId=74f180652b9, topicName=职称)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c3811138989, createdName=xxxx1053, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1552455, encodeId=51481552455de, content=<a href='/topic/show?id=a8d5196997c' target=_blank style='color:#2F92EE;'>#三甲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=19699, encryptionId=a8d5196997c, topicName=三甲)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88e914287502, createdName=陈吴1239, createdTime=Fri Apr 20 13:49:00 CST 2018, time=2018-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=307462, encodeId=a89b30e46264, content=非常好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Fri Apr 20 06:00:47 CST 2018, time=2018-04-20, status=1, ipAttribution=)]
    2018-04-20 swfzhanggui

    非常好.谢谢分享

    0

相关资讯

湖北四方面发力落实分级诊疗

1月28日,湖北省卫生计生委党组书记张晋在湖北省两会新闻发布会上表示,该省将坚持“以基层为重点”的新时代卫生与健康工作方针,以“四强”基层为主要措施,促进医疗卫生工作重心下移、资源下沉。

湖北秭归患癌村医坚守救护一线,7年为乡亲看病4万余人次

“只要还没有倒下,我就要继续为乡亲们看病。”湖北省秭归县茅坪镇长岭村村医向方洪23日受访时说道。身患癌症7年的他,坚守在村卫生室为乡亲看病4.7万人次。向方洪今年61岁,早年因患白内障,左眼失明。2011年4月,他又被查出肺癌,手术切除了病变的右肺。虽然有病在身,但是向方洪想到的不是离职疗养,而是继续与癌魔抗争,为乡亲们效力。与向方洪共事20年的长岭村党总支原书记韩庆国表示,向方洪学历不高,但为人

湖北中医药投资基金启动,5亿元助推中医药健康服务现代化

由湖北省省级股权投资引导基金和武汉市战略性新兴产业发展引导基金共同参与、支持的湖北省首个中医药投资基金4月3日在武汉启动。该基金总规模达5亿元,旨在助推传统中医药健康服务向多方位、现代化方向迈进。

湖北构建三级联动县域医疗体系

近日,湖北省卫生计生委印发《关于推进县域医疗共同体建设的意见》,决定以推进县域医疗共同体为切入点,构建起县、乡、村三级联动的县域医疗服务体系,加快建立健全分级诊疗制度。

湖北着力打通药品供应短缺的“肠梗阻”

药品短缺问题成因复杂,涉及研发注册、生产流通、采购使用等各个环节。近日,湖北提出着力构建全省短缺药品供应保障工作会商联动机制,将重在打通信息收集、采购使用等环节“肠梗阻”,进一步加强涉药管理部门协调,建立长效运行机制,减少药品短缺发生频次。这是湖北省卫计委等十部门联合印发《关于改革完善短缺药品供应保障机制的实施方案》中提到的。按照要求,湖北全省短缺药品监测系统要不断扩大覆盖范围,逐步实现全省每个

湖北8家部省属医院被责令整改

近日,湖北省卫计委发布《2017年部省属医疗机构依法执业“双随机一公开”检查情况》的公告。